Ectodermal placode development

pathway activity — cross-omics
GO:0071696Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Ectodermal placode development pathway is significantly associated with the RNA expression of multiple genes, with the OV cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are SMYD3-IT1, TBX2, and NAGA, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Ectodermal placode development activity versus SMYD3-IT1 in OV (Pearson r = 0.17).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
OVSMYD3-IT1 →+0.184+0.983<.001<.00134
CCRCCTBX2 →+0.876+0.193.002.00133
PDACNAGA →-0.279-0.481.003.00133
UCECTBX3 →+1.037+0.643.001<.00133
CCRCCABCG2 →+0.730+0.187.004<.00133
CCRCCAPOC1 →-1.423-0.235<.001<.00133
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0071696 vs SMYD3-IT1 — OV

Per-sample scatter of Ectodermal placode development activity vs SMYD3-IT1 in OV.

Explore this scatter interactively →

Exploration